Infectious Disease Analyst
Current• Independently lead and support briefings for esteemed clients including the UK Health Security Agency and UNICEF, providing strategic insights and tailored recommendations on emerging health threats and countermeasures• Deliver in-depth, bespoke epidemiological analyses on mpox for major clients, such as the White House and Bavarian Nordic, focused on the interplay between health determinants, and disease impact, providing actionable insights to inform policy and strategic decisions• Author monthly reports on advancements in vaccine development for infectious diseases, highlighting clinical progress and competition analysis• Maintain and quality check a database comprising ~3000 vaccine medical countermeasures, including respective clinical trials and regulatory approvals, supervising a team of 2-3 external researchers to ensure data relevancy and correctness • Abstract selected for presentation at IDWeek 2024: ‘The Potential Impact of Vaccination on Clade I Mpox Cases in the Democratic Republic of Congo and Risk of Importation to the United States from International Travel’ (Role: First Author)